Could Utah Medical Products, Inc. (UTMD) Change Direction After Achieving All Time High?

April 17, 2018 - By Adrian Mccoy

Investors sentiment increased to 1.75 in 2017 Q4. Its up 0.18, from 1.57 in 2017Q3. It improved, as 5 investors sold Utah Medical Products, Inc. shares while 19 reduced holdings. 14 funds opened positions while 28 raised stakes. 2.40 million shares or 0.23% less from 2.41 million shares in 2017Q3 were reported.
Wedge Mngmt L L P Nc accumulated 0% or 4,900 shares. 3,745 are owned by First Quadrant L P Ca. Acadian Asset Lc has 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD) for 1,598 shares. Metropolitan Life Ny reported 1,319 shares. Manufacturers Life Insur Com The stated it has 2,944 shares. Advisory Svcs Ntwk Llc holds 3,690 shares. Renaissance Tech Ltd Liability Corp holds 0.02% in Utah Medical Products, Inc. (NASDAQ:UTMD) or 212,200 shares. Wells Fargo And Com Mn reported 28,464 shares stake. Rhumbline Advisers holds 0% or 3,209 shares. Hancock Com owns 2,937 shares for 0.01% of their portfolio. 70,358 are owned by Ancora Advisors Lc. 3,000 are owned by Spark Lc. 4,000 were accumulated by Ny State Common Retirement Fund. Northern accumulated 52,860 shares. 296 are owned by Ameritas Invest Prns.

Since February 2, 2018, it had 0 insider buys, and 8 selling transactions for $1.56 million activity. HOYER ERNST G sold 5,212 shares worth $464,447. Another trade for 1,000 shares valued at $90,700 was sold by PAYNE BARBARA A.

The stock of Utah Medical Products, Inc. (NASDAQ:UTMD) reached all time high today, Apr, 17 and still has $105.68 target or 3.00 % above today’s $102.60 share price. This indicates more upside for the $382.26M company. This technical setup was reported by Barchart.com. If the $105.68 PT is reached, the company will be worth $11.47 million more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock increased 3.32% or $3.3 during the last trading session, reaching $102.6. About 18,095 shares traded or 5.23% up from the average. Utah Medical Products, Inc. (NASDAQ:UTMD) has risen 57.70% since April 17, 2017 and is uptrending. It has outperformed by 46.15% the S&P500.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide. The company has market cap of $382.26 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It has a 45.08 P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

Utah Medical Products, Inc. (NASDAQ:UTMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.